Clinical trial Recruiting at 3 sites Observational Ages 5 to 80

Long-term brain-signal monitoring after GPi DBS for dystonia

Official title: Chronic Neurophyhsiological and Kinematic Biomarker Monitoring in Patients With Dystonia and Pallidal Deep Brain Stimulation

Run by Charite University, Berlin, Germany · NCT07244549 · Data updated 2026-11-12

This project will try to find brain-signal patterns recorded from a sensing-enabled DBS device in people with dystonia to help personalize and speed up stimulation care over the first postoperative year.

More Dystonia trials

Quick facts

Study typeObservational
Ages5 Years to 80 Years
SexAll
Enrollment25 (estimated)
SponsorCharite University, Berlin, Germany
Academic / other
Locations3 sites (Hanover, Lower Saxony and 2 other locations)
StatusRecruiting
StartedAugust 16, 2024
Main results expectedMarch 30, 2028
Study endsMarch 30, 2028
Registry record updatedNovember 24, 2025
Trial IDNCT07244549 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 5–80 with a clinical diagnosis of dystonia who plan to receive GPi DBS and agree to have the sensing-enabled Percept neurostimulator implanted and to attend follow-up visits.

Probably not a fit

Patients who will not receive a sensing-enabled device, are not undergoing GPi DBS, or have severe psychiatric or medical comorbidities that preclude participation are unlikely to benefit from this project.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational, multicenter project enrolling people with dystonia who are receiving GPi deep brain stimulation with the Percept sensing-enabled neurostimulator. The device will record intracranial local field potentials, including during active stimulation, and researchers will track these signals repeatedly over the first year after surgery. The team will examine low-frequency (theta/alpha) and beta-band activity, day/night (circadian) changes, and how signal patterns relate to symptom changes and stimulation settings. The goal is to identify chronic electrophysiological biomarkers that could guide faster and more individualized DBS programming or future closed-loop approaches.

Why it matters

Potential benefit: If successful, the findings could shorten the time needed to find effective DBS settings and enable more personalized or automatic stimulation adjustments to improve symptoms.

How similar studies have gone: Prior laboratory recordings and a small number of case reports have suggested low-frequency activity as a dystonia biomarker, but systematic long-term data with the Percept device in dystonia are currently limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ability to give informed consent for the study, or in pediatric patients, legal guardian or parent willing to give informed consent
* Diagnosis of dystonia, which may be isolated or generalized
* Wish to receive surgical intervention with DBS to the internal pallidal globe (GPi)
* Decision to receive the sensing-enabled neurostimulator (Percept neurostimulator) PC/RC
* Age 5-80 years

Exclusion Criteria:

* Severe psychiatric disorders (BDI\>20)
* Other severe medical conditions, that may interfere with the successful paritcipation in the study protocol
* No consent given

Where it's running

  • Medizinische Hochschule Hannover
    Hanover, Lower Saxony, Germany
    Recruiting
  • Heinrich Heine University
    Düsseldorf, Nordrhein-Westfahlen, Germany
    Recruiting
  • Charité Universitätsmedizin Berlin
    Berlin, State of Berlin, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.